Tata Chemicals Q2: India EBITDA Up ₹52 Crore, the US Unit Down ₹100 Crore, in a Weak Soda Ash Market

Tata Chemicals reported standalone (India) EBITDA of ₹292 crore for July-September 2026 against ₹240 crore a year earlier, up 22%, and a consolidated loss for the period of ₹50 crore against a profit of ₹154 crore in the consolidated statement (the press release and deck compare it with ₹219 crore, which is the company's continuing-operations figure before exceptional items and minority interest). The company's unit table in the investor presentation shows where the difference sits: the US unit's EBITDA went from ₹77 crore to a loss of ₹23 crore on revenue that rose 16% (our arithmetic), the UK unit's from ₹39 crore to ₹9 crore, and Kenya's from ₹18 crore to a loss of ₹20 crore. Soda ash volume was flat at 851 thousand tonnes against 850. The filings give no cost per tonne; our reading is that a soda ash cost advantage here looks like a property of individual plants and freight routes, not of the company.

The idea in one sentence

If Tata Chemicals had one soda ash cost position, one global price would move all its units the same way; this quarter India's EBITDA rose and the US unit's fell in the same global market, although India's rise shows up in salt and bicarbonate, not soda ash, so the moat has to be read plant by plant and route by route (our reading).

The fact that breaks the assumption

The headline reads as a healthy core inside a loss-making group. The press release says it directly. Standalone: "EBITDA at ₹ 292 Cr, up by 22% compared to Q2FY26". Consolidated: EBITDA of ₹381 crore against ₹537 crore, "mainly due to lower realisations in overseas subsidiaries, especially US exports to South-East Asia markets, higher energy and logistics costs in UK, temporary suspension of operations in Kenya" [PR].

Two things in the statements cut across that tidy picture. First, the rise in India's segment result is not in soda ash. In the standalone segment note [RS], Living Essentials (salt, sodium bicarbonate, prebiotics) earned a segment result of ₹192 crore against ₹164 crore, while Industrial Essentials (soda ash, silica, industrial chemicals) earned ₹31 crore against ₹33 crore, and ₹111 crore in the June quarter. The standalone segment result rose ₹26 crore in total, and Living Essentials alone rose ₹28 crore, so Industrial Essentials contributed nothing to the rise in the segment result (our arithmetic; these are segment results, not EBITDA). Second, India's EBITDA gain did not reach India's profit. Standalone profit before tax fell to ₹152 crore from ₹212 crore, and profit after tax to ₹122 crore from ₹178 crore, down 31.5% (our arithmetic; the company prints 31%).

One concrete thing, followed: the US unit's row

Take one row of one table. [IP] slide 13 gives a unit-wise profit and loss. For the US, the quarter column reads: revenue ₹1,492 crore against ₹1,282 crore a year earlier; EBITDA ₹(23) crore against ₹77 crore; profit before tax ₹(195) crore against ₹(84) crore. Revenue grew 16.4% (our arithmetic) and EBITDA moved by ₹100 crore the wrong way. The slide's own words for the US are "Higher revenue driven by higher volume" and "Net realisations lower due to unremunerative pricing in South-East Asia." The CEO says in the press release that "Exports from the US to Southeast Asia were particularly impacted by unremunerative pricing" [PR].

That is a unit selling more tonnes and earning less in total. Group-wide, the deck's EBITDA bridge says the same thing in three numbers: volume and mix ₹+72 crore, price ₹(129) crore, fixed cost ₹(99) crore, taking EBITDA from ₹537 crore to ₹381 crore (slide 5). The deck footnotes that "Price includes cost, forex and other" on the half-year bridge (slide 6); slide 5 carries no such footnote, so if the quarter's ₹(129) crore is defined the same way (our reading), it is not a pure selling-price figure; the filings give no soda ash price per tonne.

The mechanism: the same price, different plants, different freight

Our reading, general industry logic and not a filing statement: a soda ash producer's margin is the gap between the market price and the producer's own delivered cost. The filings give the consolidated cost lines and, in words, how each unit was hit.

Delivered cost is large and rose faster than revenue. Consolidated freight and forwarding charges were ₹949 crore against ₹716 crore, up 32.5%, while revenue rose 7.7% (our arithmetic). Power and fuel rose 21.0%, to ₹535 crore from ₹442 crore (our arithmetic). Together they were 35.5% of consolidated revenue against 29.9% (our arithmetic). The cost of materials, purchases and inventory change together was ₹984 crore against ₹968 crore, so, on our reading, raw materials were not what squeezed the margin. The press release says "The prolonged Middle East conflict continued to drive inflation in key inputs, including limestone and CO₂, as well as energy, freight, and logistics costs across our operations" [PR].

Where the plant sits decides who pays that bill. The company ties the UK result to "high input energy costs and logistics disruption due to prolonged Middle East conflict" (slide 13), and the CEO to "a sharp rise in UK natural gas costs" [PR]. UK EBITDA was ₹9 crore against ₹39 crore on revenue of ₹386 crore against ₹396 crore. The US unit ships to Southeast Asia, where, in the company's words, pricing is unremunerative. The India unit, on the company's account, had "Higher revenue on account of higher volumes in Salt & higher realization across products" and "Variable cost impacted by inputs cost increase" (slide 13). So the cost pressure in India was real; these pages do not describe, for India, an export route priced below cost or a sharp rise in gas costs, as they do for the US and the UK.

The India profit is partly spent on the overseas units. Standalone EBITDA rose ₹52 crore, but below EBITDA three lines moved against it: finance costs rose to ₹76 crore from ₹46 crore, depreciation to ₹118 crore from ₹103 crore, and other income fell to ₹54 crore from ₹121 crore, which together explain the ₹60 crore fall in profit before tax (our arithmetic). The deck says India's finance costs were higher "as overseas debt refinanced through India" (slide 13). Standalone borrowings including leases were ₹3,476 crore against ₹2,010 crore a year earlier. In the half-year the standalone cash flow shows ₹997 crore of "Purchase of non-current investments", set against ₹796 crore of "Proceeds from redemption of non-current investments"; the filings do not say which subsidiaries received it. Our reading, anchored to the deck's sentence: the parent's profit is being diluted by carrying debt that used to sit abroad.

What the soda ash market is doing, in the company's words

Slide 4 lists the cycle in bullets: "Persistent soda ash oversupply", "US exports to Southeast Asia face unremunerative pricing" and "Supply growth, soft demand and changing trade flows continue to limit pricing power". The CEO says the outlook for soda ash is "challenging due to excess global capacity, weak pricing and geopolitical and cost pressures" [PR]. The company's response is stated as priorities: "operational excellence, structural cost reduction, cash generation and disciplined capital allocation" [PR], and, in the soda ash business, "optimising our global manufacturing and supply chain footprint, and serving markets where we can generate sustainable value" [PR]. Our reading: the second quote implies that some markets served today do not generate value. That would be a footprint decision, and the filings give no plant, route or date.

Where this breaks

• The India "cost position" is not shown. The filings contain no cost per tonne, so a cost advantage in India is our inference from a segment result, and that result is thin. Standalone Industrial Essentials earned ₹31 crore on revenue of ₹668 crore, 4.6% (our arithmetic), against ₹33 crore on ₹675 crore a year earlier and ₹111 crore on ₹698 crore in the June quarter. Standalone revenue is not all soda ash and the filings do not split it. Standalone EBITDA also fell from ₹364 crore in Q1 to ₹292 crore in Q2, down 19.8% (our arithmetic), so the 22% gain is year on year only; EBITDA fell from the June quarter.
• The strongest case against our reading is the company's own. The deck headline reads "Higher input and fixed cost lead to lower consolidated EBITDA; standalone EBITDA, however, improved YoY" (slide 7). That is the picture an investor sees, and the US unit's loss may be mostly a pricing episode in one export lane (the deck says "Net realisations lower due to unremunerative pricing in South-East Asia"). If the lane recovers, the unit table need not say anything permanent about the US cost position.
• The US cost position was already questioned. Note 2(b) of [RS] says conditions "had negatively impacted the performance of US business" and records a goodwill impairment of ₹1,837 crore in the year ended 31 March 2026. A reader who took the US as the low-cost anchor of the group should read that note first.
• Kenya is a separate story and a small number so far. Note 6 says the ministry directed the subsidiary "to suspend its mining operations and exports pending the compliance review" and that the group incurred a loss of ₹21 crore in the quarter. Management "believes that currently there is no impairment of property, plant and equipment". Kenya revenue fell to ₹71 crore from ₹129 crore (our arithmetic: down 45%), and EBITDA moved from ₹18 crore to ₹(20) crore. That belief is management's; the filings give no date for reopening, and the 24 October digest recorded the High Court of Kenya holding that it has no jurisdiction in the dispute.
• Review, not audit, on the consolidated side. B S R & Co. LLP's consolidated conclusion is unmodified, and in both paragraphs about unreviewed joint venture, associate and other-auditor information the report says "Our conclusion is not modified in respect of this matter." The standalone results are audited, with an unmodified opinion. A review is "substantially less in scope than an audit".
• No call. The call was held on 7 November and only an audio link was filed. Any explanation management gave of the Q1-to-Q2 fall in India's soda ash profit, or of the borrowings move, is not in this piece.

Why it costs the reader something

A reader who sees standalone EBITDA up 22% beside a consolidated loss and concludes that the core is fine and the subsidiaries are the problem has to explain why the group's capital is where it is. Consolidated external net debt was ₹6,127 crore against ₹5,961 crore in March (company figure, [IP] slide 4), operating cash flow for the half-year was ₹64 crore against ₹536 crore, and capital expenditure was ₹511 crore ([RS] cash flow, our reading of the two lines together: the group did not fund its capex from operations this half-year). The segment that made the loss, consolidated Industrial Essentials, carries ₹18,678 crore of the ₹28,036 crore of segment assets (our arithmetic: 67%). What would let a reader separate a lane in trouble from a plant out of the cost curve is not in the documents: cost per tonne by plant, and export share by route.

The concrete thing, again

One row: US revenue ₹1,492 crore, EBITDA ₹(23) crore. It is the only unit in the table with a year-ago base that grew revenue by more than ten per cent while posting an EBITDA loss (Novabay has no year-ago revenue to compare), and it sits beside an India row that earned ₹292 crore. The two rows sit in the same global soda ash market, though the India row is not soda ash alone (it includes salt and bicarbonate, and the filings do not split it). Our reading: what Tata Chemicals owns in soda ash is not one cost position but several, and this quarter's table shows them being priced differently. Until a filing gives cost per tonne by plant, the cost-advantage moat is an inference from where the profit sits, and the standalone segment result sits mainly in India's salt and bicarbonate (Living Essentials ₹192 crore of ₹223 crore, our arithmetic).

Sources

• [RS] Tata Chemicals, outcome of the board meeting, results and auditors' reports, 7 Nov 2026 (NSE)
• [PR] Tata Chemicals, press release on Q2 and H1 FY27 results, 7 Nov 2026 (NSE)
• [IP] Tata Chemicals, Q2 and H1 FY27 investor presentation, 7 Nov 2026 (NSE)
• [AU] Tata Chemicals, audio recording of the analysts' call, 7 Nov 2026 (NSE; not listened to)
• Moat & Margin on the company: Tata Chemicals moat analysis
• Earlier digest note on Kenya: Daily filing digest, 24 Oct 2026

Educational research, not investment advice. Every figure above is drawn from Tata Chemicals' own filings of 7 November 2026 (results with the limited review report and audit report, the press release and the investor presentation; the earnings call was held that day and no transcript was read), read from the primary documents on 8 November 2026; derived figures are our arithmetic, labelled as such. MoatSCORE: 5.78 (read live on the Moat Screener on 8 Nov 2026, where it is labelled first-pass; provisional). No buy/sell recommendations, no price targets, no share prices. Moat & Margin is not a SEBI-registered Research Analyst or Investment Adviser.